A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery
- 1 March 2003
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 188 (3) , 836-843
- https://doi.org/10.1067/mob.2003.185
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Antenatal Seroprevalence of Herpes Simplex Virus Type 2 (HSV-2) in Canadian WomenSexually Transmitted Diseases, 2001
- Herpes simplex virus antiviral drug resistance — current trends and future prospectsJournal of Clinical Virology, 2001
- Genital herpes during pregnancy: Inability to distinguish primary and recurrent infections clinicallyObstetrics & Gynecology, 1997
- Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment.Journal of Clinical Investigation, 1997
- Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancyAmerican Journal of Obstetrics and Gynecology, 1997
- Acyclovir Suppression to Prevent Cesarean Delivery After First-Episode Genital HerpesObstetrics & Gynecology, 1996
- Virologic Characteristics of Subclinical and Symptomatic Genital Herpes InfectionsNew England Journal of Medicine, 1995
- Acyclovir in late pregnancy to prevent neonatal herpes simplexThe Lancet, 1990
- Changing Presentation of Herpes Simplex Virus Infection in NeonatesThe Journal of Infectious Diseases, 1988
- Failure of Antepartum Maternal Cultures to Predict the Infant's Risk of Exposure to Herpes Simplex Virus at DeliveryNew England Journal of Medicine, 1986